New York Heart Association Functional Classification (NYHA)
The NYHA Functional Classification groups heart failure patients based on physical limitations. Clinicians use this simple tool to assess symptom severity and plan treatment.
New York Heart Association Functional Classification (NYHA)
The New York Heart Association Functional Classification (NYHA) categorises heart failure patients into four classes based on physical limits. It's a standard method to assess symptom severity during activity. This scale helps guide therapy choices and tracks how well a patient manages daily tasks.
Category
Disease
Source
What is New York Heart Association Functional Classification (NYHA)
The New York Heart Association Functional Classification (NYHA) helps doctors rate heart failure severity based on how patients handle daily tasks. It places patients into one of four distinct categories based on their limits. This system looks at how much physical effort triggers common issues like shortness of breath or tiredness. Class I means you have no limits on activity while Class II involves slight limits. Class III indicates marked limits where simple moves cause trouble and Class IV describes severe cases where symptoms happen even while resting or sitting still. Doctors use this scale during routine check-ups to track if a condition is getting better or worse over time. It is quick to use and does not need special equipment so it fits well in busy clinics. It helps medical teams decide on the best treatment plans to keep hearts healthy and patients active.
The New York Heart Association Functional Classification is scored using a single approach based on physical limits. Clinicians assign patients to one of four functional classes based on physical activity. Class I means no limits on ordinary movement. Class II involves slight limits where you are comfy at rest but get puffed easily. Class III shows marked limits with comfort only at rest. Class IV is the most severe, where symptoms occur even while resting. This straightforward system helps doctors track disease progression and decide on the best treatment plans.
Advantages
Develops personalised strategies based on assessment data.
.svg){kind=icon}
Meets international clinical assessment requirements.
.svg){kind=icon}
Simple to understand and complete for patients.
.svg){kind=icon}
Measures healthcare intervention results systematically.
.png){kind=icon}
Related Instruments
Screens for neuropathic pain components.
Predicts long-term disability risk in musculoskeletal pain.
Assesses symptoms and function in lumbar spinal stenosis.
Collect NYHA data with WeGuide, the all in one patient engagement platform
Support Your patient in no time - all under your own brand
Our platform combines the knowledge of 100+ digital health solutions built, letting you easily build your patient engagement app for research or clinical use. Collect PROMs, support patients on waiting lists, or gather vital signs data. This is how:
Learn More.png){kind=icon}
Program Builder
.png)
.png){kind=icon}
Whitelabelling
.svg)
.svg)
.png){kind=icon}
Turn on components, dependent on your usecase
.svg)
.png){kind=icon}
Support The Full Journey
.png)
.png)
%20(1).png)
.png)
It’s your turn
Every WeGuide project, saves researchers and clinicians - 9 months and $450,000 - creating impactful digital health solutions.
